CAS 419573-20-9
:N-[[(3S,6R)-5-amino-6-[(1R,4R,6R)-4,6-diamino-3-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-3-hydroxy-tetrahydropyran-2-yl]methyl]-12-[5-[(4S)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]p
Description:
The chemical substance with the name "N-[[(3S,6R)-5-amino-6-[(1R,4R,6R)-4,6-diamino-3-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-3-hydroxy-tetrahydropyran-2-yl]methyl]-12-[5-[(4S)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]p" and CAS number "419573-20-9" is a complex organic molecule characterized by its intricate structure, which includes multiple chiral centers and functional groups. This compound features amino groups, hydroxyl groups, and a thieno[3,4-d]imidazole moiety, indicating potential biological activity. Its stereochemistry suggests that it may interact specifically with biological targets, making it of interest in pharmaceutical research. The presence of multiple tetrahydropyran rings and cyclohexane derivatives may contribute to its solubility and stability in biological systems. Overall, the compound's unique structural features and functional groups suggest it could have applications in medicinal chemistry, particularly in the development of therapeutics targeting specific biological pathways.
Formula:C40H74N8O12S
InChI:InChI=1/C40H74N8O12S/c41-21-16-22(42)37(60-39-34(54)31(44)33(53)27(19-49)58-39)35(55)36(21)59-38-23(43)17-25(50)26(57-38)18-46-30(52)13-8-6-4-2-1-3-5-7-11-15-45-29(51)14-10-9-12-28-32-24(20-61-28)47-40(56)48-32/h21-28,31-39,49-50,53-55H,1-20,41-44H2,(H,45,51)(H,46,52)(H2,47,48,56)/t21-,22-,23?,24?,25+,26?,27?,28+,31+,32?,33-,34?,35?,36-,37?,38-,39-/m1/s1
Synonyms:- N-BIOTINYL-12-AMINODODECANOYLTOBRAMYCIN AMIDE
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
N-Biotinyl-12-aminododecanoyltobramycin amide
CAS:<p>N-Biotinyl-12-aminododecanoyltobramycin amide is a synthetic bioconjugate, which is derived from the aminoglycoside antibiotic tobramycin. This compound is chemically modified by the addition of a biotin moiety linked through a 12-aminododecanoyl spacer. The source of this product is rooted in the conjugation of biotin to tobramycin, allowing for targeted delivery and potential hybrid applications in both therapeutic and diagnostic fields.</p>Formula:C40H74N8O12SPurity:Min. 95%Molecular weight:891.13 g/mol

